SightfileU.S. market data from official filings

BIO-TECHNE CORP (TECH)

Name: BIO-TECHNE CORP (TECH) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000842023 · EDGAR filings · Updated 2026-07-27

BIO-TECHNE CORP (TECH) has reported institutional ownership of 113.3%, with 579 institutional managers holding positions valued at $9.29B per the latest 13F reporting period.

Institutional ownership

113.3%

Institutional managers

579

Reported 13F value

$9.29B

Insider activity

47 trans.

−$2.10M net selling

Filings this week (1)

2026-07-27 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-09 — DEFA14A filed
2026-06-26 — Current report (8-K) filed
2026-06-25 — DEFA14A filed
2026-06-25 — Current report (8-K) filed
2026-06-04 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BIO-TECHNE CORP has 579 institutional holders and institutional ownership of 113.3%.

Insider activity

Insiders reported 47 transactions (0 buys, 4 sells) across 15 reporting insiders, with a net reported value of −$2.10M.

Related companies

VAXCYTE INC (PCVX) · GLOBUS MED INC (GMED) · ENCOMPASS HEALTH CORP (EHC) · BRIGHTSPRING HEALTH SVCS INC (BTSG) · BAXTER INTL INC (BAX) · ICON PLC (ICLR)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.